Edgen Stock·Dec 17 2025, 03:36Back
Guardant Health Data Targets Breast Cancer Standard
Edgen Stock·Dec 17 2025, 03:36
[1] Enhertu moves into frontline breast cancer treatment - pharmaphorum (https://pharmaphorum.com/news/enhertu-moves-f ...)[2] Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis - Nature (https://www.nature.com/articles/s41416-025-03 ...)[3] BPGbio Announces Publication of Pioneering Solid Tumor Study with BPM31510 IV using Patient Omics and Bayesian AI to Guide Clinical Development - BioSpace (https://www.biospace.com/press-releases/bpgbi ...)
